Taking stock of Nostoc: Secondary metabolite analyses with an outlook for future therapeutic leads
Innovative Medicines & Omics · 07.04.2026 · 3 (2) · 025490070
DOI: 10.36922/imo025490070 ↗Kurz gefasst
Fachartikel in der Zeitschrift Innovative Medicines & Omics, online erschienen am 07.04.2026. Verfasst von Kalyani Ajayan und 3 weiteren Autor:innen.
Abstract (Originalsprache)
Natural products derived from cyanobacteria have emerged as a prolific source of structurally diverse and biologically active compounds with significant therapeutic potential. This review summarizes the current literature on the isolation of natural products and their medicinal properties from the cyanobacterial genus Nostoc. It emphasizes the structural diversity of secondary metabolites biosynthesized by Nostoc. Based on the literature on the chemical characterization of natural products, we provide an outlook for harnessing the latent biocatalytic potential of this cyanobacterial genus to discover enzymes directly involved in the production of these diverse natural products. The review provides potential hints for future identification of enzymes with unique biochemistry and/or for the synthesis of novel natural product analogs from the families discussed herein.
Zitieren
APA
Ajayan, K., Sushaman, K. P., Krishnamurthy, N., & Viswanathan, R. (2026). Taking stock of Nostoc: Secondary metabolite analyses with an outlook for future therapeutic leads. Innovative Medicines & Omics, 3(2), 025490070. https://doi.org/10.36922/imo025490070
Vancouver
Ajayan K, Sushaman KP, Krishnamurthy N, Viswanathan R. Taking stock of Nostoc: Secondary metabolite analyses with an outlook for future therapeutic leads. Innovative Medicines & Omics. 2026;3(2):025490070. doi:10.36922/imo025490070
BibTeX
@article{Ajayan2026,
author = {Ajayan, Kalyani and Sushaman, Krishna Priya and Krishnamurthy, Nirmala and Viswanathan, Rajesh},
title = {Taking stock of Nostoc: Secondary metabolite analyses with an outlook for future therapeutic leads},
journal = {Innovative Medicines & Omics},
year = {2026},
volume = {3},
number = {2},
pages = {025490070},
doi = {10.36922/imo025490070}
}
EUVIMED